Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kalnisha Naidoo
Institutions:
Institute of Cancer Research,
Breast Cancer Now
Observed institutions:
Institute of Cancer Research,
Breast Cancer Now
ORCID:
0000-0002-9253-619X
Observed ORCID:
0000-0002-9253-619X
OpenAlex ID:
A5049720751
Dynamic Changes in the NK-, Neutrophil-, and B-cell Immunophenotypes Relevant in High Metastatic Risk Post Neoadjuvant Chemotherapy–Resistant Early Breast Cancers
2022
·
Patrycja Gazinska
, Charlotte Milton
, et al.
·
Clinical Cancer Research
·
27
PDF
3D Functional Genomics Screens Identify CREBBP as a Targetable Driver in Aggressive Triple-Negative Breast Cancer
2021
·
Barrie Peck
, Philip Bland
, et al.
·
Cancer Research
·
24
PDF
Supplementary Table Descriptions from Evaluation of CDK12 Protein Expression as a Potential Novel Biomarker for DNA Damage Response–Targeted Therapies in Breast Cancer
2023
·
Kalnisha Naidoo
, Patty T. Wai
, et al.
Supplementary Tables S1-S10 from Evaluation of CDK12 Protein Expression as a Potential Novel Biomarker for DNA Damage Response–Targeted Therapies in Breast Cancer
2023
·
Kalnisha Naidoo
, Patty T. Wai
, et al.
Data from Evaluation of CDK12 Protein Expression as a Potential Novel Biomarker for DNA Damage Response–Targeted Therapies in Breast Cancer
2023
·
Kalnisha Naidoo
, Patty T. Wai
, et al.
Supplementary Figure from Dynamic Changes in the NK-, Neutrophil-, and B-cell Immunophenotypes Relevant in High Metastatic Risk Post Neoadjuvant Chemotherapy–Resistant Early Breast Cancers
2023
·
Patrycja Gazinska
, Charlotte Milton
, et al.
Supplementary Figure from Dynamic Changes in the NK-, Neutrophil-, and B-cell Immunophenotypes Relevant in High Metastatic Risk Post Neoadjuvant Chemotherapy–Resistant Early Breast Cancers
2023
·
Patrycja Gazinska
, Charlotte Milton
, et al.
Supplementary Figure from Dynamic Changes in the NK-, Neutrophil-, and B-cell Immunophenotypes Relevant in High Metastatic Risk Post Neoadjuvant Chemotherapy–Resistant Early Breast Cancers
2023
·
Patrycja Gazinska
, Charlotte Milton
, et al.
PDF
Supplementary Figure from Dynamic Changes in the NK-, Neutrophil-, and B-cell Immunophenotypes Relevant in High Metastatic Risk Post Neoadjuvant Chemotherapy–Resistant Early Breast Cancers
2023
·
Patrycja Gazinska
, Charlotte Milton
, et al.
Data from 3D Functional Genomics Screens Identify CREBBP as a Targetable Driver in Aggressive Triple-Negative Breast Cancer
2023
·
Barrie Peck
, Philip Bland
, et al.
Supplementary Methods from 3D Functional Genomics Screens Identify CREBBP as a Targetable Driver in Aggressive Triple-Negative Breast Cancer
2023
·
Barrie Peck
, Philip Bland
, et al.
PDF
Table S1 from 3D Functional Genomics Screens Identify CREBBP as a Targetable Driver in Aggressive Triple-Negative Breast Cancer
2023
·
Barrie Peck
, Philip Bland
, et al.
Figure S1- S8 from 3D Functional Genomics Screens Identify CREBBP as a Targetable Driver in Aggressive Triple-Negative Breast Cancer
2023
·
Barrie Peck
, Philip Bland
, et al.
Table S2 from 3D Functional Genomics Screens Identify CREBBP as a Targetable Driver in Aggressive Triple-Negative Breast Cancer
2023
·
Barrie Peck
, Philip Bland
, et al.
Table S3 from 3D Functional Genomics Screens Identify CREBBP as a Targetable Driver in Aggressive Triple-Negative Breast Cancer
2023
·
Barrie Peck
, Philip Bland
, et al.
Table S5 from 3D Functional Genomics Screens Identify CREBBP as a Targetable Driver in Aggressive Triple-Negative Breast Cancer
2023
·
Barrie Peck
, Philip Bland
, et al.
Table S4 from 3D Functional Genomics Screens Identify CREBBP as a Targetable Driver in Aggressive Triple-Negative Breast Cancer
2023
·
Barrie Peck
, Philip Bland
, et al.
Data from Dynamic Changes in the NK-, Neutrophil-, and B-cell Immunophenotypes Relevant in High Metastatic Risk Post Neoadjuvant Chemotherapy–Resistant Early Breast Cancers
2023
·
Patrycja Gazinska
, Charlotte Milton
, et al.
Supplementary Data from Dynamic Changes in the NK-, Neutrophil-, and B-cell Immunophenotypes Relevant in High Metastatic Risk Post Neoadjuvant Chemotherapy–Resistant Early Breast Cancers
2023
·
Patrycja Gazinska
, Charlotte Milton
, et al.
Supplementary Figure from Dynamic Changes in the NK-, Neutrophil-, and B-cell Immunophenotypes Relevant in High Metastatic Risk Post Neoadjuvant Chemotherapy–Resistant Early Breast Cancers
2023
·
Patrycja Gazinska
, Charlotte Milton
, et al.
Supplementary Figure from Dynamic Changes in the NK-, Neutrophil-, and B-cell Immunophenotypes Relevant in High Metastatic Risk Post Neoadjuvant Chemotherapy–Resistant Early Breast Cancers
2023
·
Patrycja Gazinska
, Charlotte Milton
, et al.
PDF
Supplementary Figure from Dynamic Changes in the NK-, Neutrophil-, and B-cell Immunophenotypes Relevant in High Metastatic Risk Post Neoadjuvant Chemotherapy–Resistant Early Breast Cancers
2023
·
Patrycja Gazinska
, Charlotte Milton
, et al.
PDF
Supplementary Figure from Dynamic Changes in the NK-, Neutrophil-, and B-cell Immunophenotypes Relevant in High Metastatic Risk Post Neoadjuvant Chemotherapy–Resistant Early Breast Cancers
2023
·
Patrycja Gazinska
, Charlotte Milton
, et al.
PDF
Table S5 from 3D Functional Genomics Screens Identify CREBBP as a Targetable Driver in Aggressive Triple-Negative Breast Cancer
2023
·
Barrie Peck
, Philip Bland
, et al.
Table S1 from 3D Functional Genomics Screens Identify CREBBP as a Targetable Driver in Aggressive Triple-Negative Breast Cancer
2023
·
Barrie Peck
, Philip Bland
, et al.
Show more works
View as search
Works count:
27
Citation count:
51
H-index:
2
I10-index:
2
Year
Topic
Type